LY3971297 / Eli Lilly - LARVOL DELTA

A Study of LY3971297 in Participants With Heart Failure (clinicaltrials.gov) - P1 | N=90 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting

Enrollment open • Cardiovascular • Congestive Heart Failure • Heart Failure

A Study of LY3971297 in Healthy Participants (clinicaltrials.gov) - P1 | N=225 | Active, not recruiting | Sponsor: Eli Lilly and Company | Recruiting ➔ Active, not recruiting

Enrollment closed • Cardiovascular • Genetic Disorders • Hypertension • Obesity

A Study of LY3971297 in Participants With Heart Failure (clinicaltrials.gov) - P1 | N=90 | Not yet recruiting | Sponsor: Eli Lilly and Company | Trial completion date: Aug 2027 ➔ Nov 2027 | Trial primary completion date: Aug 2027 ➔ Nov 2027

Trial completion date • Trial primary completion date • Cardiovascular • Congestive Heart Failure • Heart Failure

A Study of LY3971297 in Participants With Heart Failure (clinicaltrials.gov) - P1 | N=90 | Not yet recruiting | Sponsor: Eli Lilly and Company

New P1 trial • Cardiovascular • Congestive Heart Failure • Heart Failure

A Study of LY3971297 in Healthy Participants (clinicaltrials.gov) - P1 | N=225 | Recruiting | Sponsor: Eli Lilly and Company | Trial completion date: Dec 2025 ➔ Sep 2026 | Trial primary completion date: Dec 2025 ➔ Sep 2026

Trial completion date • Trial primary completion date • Cardiovascular • Genetic Disorders • Hypertension • Obesity

A Study of LY3971297 in Healthy Participants (clinicaltrials.gov) - P1 | N=225 | Recruiting | Sponsor: Eli Lilly and Company | Trial completion date: Jun 2025 ➔ Dec 2025 | Trial primary completion date: Jun 2025 ➔ Dec 2025

Trial completion date • Trial primary completion date • Cardiovascular • Genetic Disorders • Hypertension • Obesity

A Study of LY3971297 in Healthy Participants and Participants With Obesity and Hypertension (clinicaltrials.gov) - P1 | N=225 | Recruiting | Sponsor: Eli Lilly and Company | Trial completion date: Feb 2025 ➔ Jun 2025 | Trial primary completion date: Feb 2025 ➔ Jun 2025

Trial completion date • Trial primary completion date • Cardiovascular • Genetic Disorders • Hypertension • Obesity

A Study of LY3971297 in Healthy Participants and Participants With Obesity and Hypertension (clinicaltrials.gov) - P1 | N=188 | Recruiting | Sponsor: Eli Lilly and Company | Trial primary completion date: Oct 2024 ➔ Feb 2025

Trial primary completion date • Cardiovascular • Genetic Disorders • Hypertension • Obesity

A Study of LY3971297 in Healthy Participants and Participants With Obesity and Hypertension (clinicaltrials.gov) - P1 | N=188 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting

Enrollment open • Cardiovascular • Genetic Disorders • Hypertension • Obesity